Blood · 2009 · 76 citations · 46 references
Life SciencesCell BiologyMolecular BiologyCell ProliferationGene ExpressionTranscriptional RegulationApoptosis RegulationCancer Cell SignalingCell Cycle Gene RegulationCell Cycle SignalingCell-cycle RegulationMultiple MyelomaCancer Cell Survival SignalingMyeloma Pathogenesis
CCAAT/enhancer-binding protein beta (C/EBPbeta), also known as nuclear factor-interleukin-6 (NF-IL6), is a transcription factor that plays an important role in the regulation of growth and differentiation of myeloid and lymphoid cells. Mice deficient in C/EBPbeta show impaired generation of B lymphocytes. We show that C/EBPbeta regulates transcription factors critical for proliferation and survival in multiple myeloma. Multiple myeloma cell lines and primary multiple myeloma cells strongly expressed C/EBPbeta, whereas normal B cells and plasma cells had little or no detectable levels of C/EBPbeta. Silencing of C/EBPbeta led to down-regulation of transcription factors such as IRF4, XBP1, and BLIMP1 accompanied by a strong inhibition of proliferation. Further, silencing of C/EBPbeta led to a complete down-regulation of antiapoptotic B-cell lymphoma 2 (BCL2) expression. In chromatin immunoprecipitation assays, C/EBPbeta directly bound to the promoter region of IRF4, BLIMP1, and BCL2. Our data indicate that C/EBPbeta is involved in the regulatory network of transcription factors that are critical for plasma cell differentiation and survival. Targeting C/EBPbeta may provide a novel therapeutic strategy in the treatment of multiple myeloma.
46
A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family.
Shizuo Akira, Hiroshi Isshiki, Takahisa Sugita et al. · The EMBO Journal · 1990 · 1.5K citations · Full text
Plasma cell differentiation requires the transcription factor XBP-1
Andreas Reimold, Neal N. Iwakoshi, John Manis et al. · Nature · 2001 · 1.3K citations
Stepwise Reprogramming of B Cells into Macrophages
Huafeng Xie, Min Ye, Ru Feng et al. · Cell · 2004 · 934 citations · Full text